Disease of Liver. Toxic Liver Disease with Hepatitis, not Elsewhere Classified
Conditions
Interventions
Intervention 1: In the intervention group (1):The end stage liver disease patients will be undertaken of ultrasound -guided in-plane internal jugular vein catheterization. Intervention 2: In the inter
Prevention
Treatment - Drugs
In the intervention group (1):The end stage liver disease patients will be undertaken of ultrasound -guided in-plane internal jugular vein catheterization.
In the intervention group (2):The end stage liver disease patients will be undertaken of ultrasound -guided out- plane internal jugular vein catheterization.
Sponsors
Vice Chancellor for Research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
14 Years to 85 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 14 years of age and over, End stage liver disease, Coagulopathy, Indication for Internal Jugular Vein Catheterization. Exclusion Criteria: Refusal for consent, Contraindication for Internal Jugular Vein Catheterization (e.g., Infection of the Site, Thyroid Enlargement, Neck Movement Limitation )
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To Determine the success rate of internal jugular vain catheterization with in-plane technique. Timepoint: at the time of catheter insertion, in the operating room, 24 hours after catheter insertion, one week after catheter insertion. Method of measurement: Observasion. | — |
Secondary
| Measure | Time frame |
|---|---|
| To Determine the success rate of internal jugular vain cathettion with out-plane techniqueeriza. Timepoint: at the time of catheter insertion, in the operating room, 24 hours after catheter insertion, one week after catheter insertion. Method of measurement: Observasion. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Nikeghbalian
Shiraz University of Medical Sciences
Outcome results
None listed